Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1997-07-07
1998-12-01
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
560 24, A61K 3124, C07C20516
Patent
active
058439951
ABSTRACT:
Tat-inhibitory oligocarbamate derivatives of the formula I ##STR1## and analogs thereof, and the biologically and pharmaceutically acceptable salts thereof exhibit advantageous properties, including specific binding to TAR RNA with high affinities, and stability of the resultant oligocarbamate-RNA complexes to proteolytic digestion. Site-specific photocrosslinking experiments using a photoactive analog (4-thio-uracil) containing TAR RNA indicate that these oligocarbamates interact with RNA in the major groove. These oligocarbamates are thus capable of competing with the TAR RNA-binding domain of Tat protein and thus are useful as a therapeutic agents in the treatment of AIDS.
REFERENCES:
Aboul-ela(1995), J. Mol. Biol., 253:313-32.
Calnan(1991), Genes Dev., 5:201-10.
Cullen(1992), Microbiol. Rev., 56:375-94.
Dintzis(1993), Proteins, 16:306-8.
Felber(1988), Science, 239;184-7.
Frankel(1988), Cell, 55:1189-94.
Hamy(1993), J. Mol. Biol., 230:111-23.
Jakobovits(1988), Mol. Cell Biol., 8:2555-61.
Milligan(1987), Nucl. Acids Res., 15:8783-98.
Milton(1992), Science, 256:1445-8.
Nordeen(1988). Biotechniques, 6:454-7.
Schumacher(1996). Science, 271:1854-7.
Stade(1989), Nucl. Acids Res., 17:9889-909.
Wang(1996), Biochemistry, 35:6491-9.
Wang(1996), J. Biol. Chem., 271:16995-8.
Zawadzke(1992), J. Am.Chem. Soc., 114:4002.
Zawadzke(1992), Proteins, 16:301-5.
Huq Ikramul
Rana Tariq M.
Richter Johann
Sackey Ebenezer
University of Medicine and Dentistry of New Jersey
LandOfFree
Inhibition of HIV-1 replication using oligocarbamate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of HIV-1 replication using oligocarbamate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of HIV-1 replication using oligocarbamate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2396093